Head-to-head · free
CME Group Inc. vs YieldMax COIN Option Income Strategy ETF
CME vs CONY — return on capital, cash generation, margins and balance sheet side by side.
CME
0 / 0
measures where CME leads
CONY
0 / 0
measures where CONY leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | CME · FY2025 | CONY |
|---|---|---|
| Revenue | $6.5B | — |
| Net income | $4.1B | — |
| Revenue growth (yearly, multi-year) | 8.6% | — |
| Free cash flow | $4.2B | — |
| Free cash flow margin | 64.3% | — |
| Net cash / (debt) | — | — |
| ROIC | 10.4% | — |
| Return on equity | 14.7% | — |
| Gross margin | 86.1% | — |
| Operating margin | 64.9% | — |
| Net debt / EBITDA | -0.22x | — |
Figures are as reported by each company; latest fiscal year shown.
Where CME Group Inc.'s cash went (FY2025)
- Capital spending
- $83.5M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free